Formerly known as Johnson & Johnson's consumer segment, Skillman-based Kenvue Inc. (KVUE) made its NYSE debut in August 2023. With a market cap of $39.3 billion, it is a global consumer health company with Self-Care, Skin Health and Beauty, and Essential Health segments.
Shares of Kenvue have underperformed the broader market considerably over the past year. KVUE has tumbled 21.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 26.2%. In 2024, KVUE stock is down 4.6%, while the SPX is up 9.5% on a YTD basis.
